Table 3.

Known groups validity. Comparison (using t-tests) of baseline AAV-PRO domain scores according to patient-reported current disease state “active” versus “in remission”.

	Current disease state	N	Mean	Std. Deviation	t	p
ORGAN SPECIFIC SYMPTOMS	Active	167	47.28	22.55	8.898	<0.0001
ORGAN SPECIFIC SYMPTOMS	Remission	425	29.35	21.86	8.898	<0.0001
SYSTEMIC SYMPTOMS	Active	168	60.75	25.37	9.525	<0.0001
SYSTEMIC SYMPTOMS	Remission	426	38.53	25.70	9.525	<0.0001
TREATMENT SIDE-EFFECTS	Active	171	48.54	22.12	9.565	<0.0001
TREATMENT SIDE-EFFECTS	Remission	422	30.59	20.09	9.565	<0.0001
SOCIAL & EMOTIONAL IMPACT	Active	172	53.54	24.17	8.079	<0.0001
SOCIAL & EMOTIONAL IMPACT	Remission	430	35.65	24.69	8.079	<0.0001
CONCERNS ABOUT THE FUTURE	Active	170	56.76	24.39	7.999	<0.0001
CONCERNS ABOUT THE FUTURE	Remission	431	38.50	25.52	7.999	<0.0001
PHYSICAL FUNCTION	Active	172	44.08	25.76	7.370	<0.0001
PHYSICAL FUNCTION	Remission	432	27.56	24.49	7.370	<0.0001